BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...
Some 39,000 years ago, a woolly mammoth died in present-day Siberia, destined to be blanketed by ice and permafrost that would end up preserving its body — even down to the hair and muscle. Now, that ...
CD Genomics, a globally distinguished pioneer in genomic technologies, declared today the induction of their innovative LncRNA Microarray Service, affording scientists an avant-garde solution for ...
A prognostic gene signature consisting of 16 inflammatory response related genes was constructed and successfully validated on multiple testing datasets. Patients in the low-risk group defined by this ...
The differentially expressed genes were categorized according to known molecular functions. A proportion was associated with transcriptional control or had unknown functions: 49.0% (246/502) in DSCL ...
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors. Giménez-Orenga et al.
In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results